(Q47768949)

5 February 2018

title

Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B. (English)

1 reference

5 February 2018

0 references

Lactococcus lactis

1 reference

Qing Gu

1

1 reference

5 February 2018

Dafeng Song

series ordinal

2

1 reference

5 February 2018

Muyuan Zhu

series ordinal

3

1 reference

5 February 2018

publication date

15 May 2009

1 reference

5 February 2018

FEMS Immunology and Medical Microbiology

published in

1 reference

5 February 2018

volume

56

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

197-203

1 reference

5 February 2018

Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Helicobacter pylori: the challenge in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

The design of vaccines against Helicobacter pylori and their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Interaction of antigens and antibodies at mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Vaccine against Helicobacter pylori: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Lactobacilli as live vaccine delivery vectors: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Prospects for the development of a vaccine against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Unidentified curved bacilli on gastric epithelium in active chronic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Lactic acid bacteria as vaccine delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2009.00566.X

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env

21 January 2018

1 reference

12 December 2020

Further development of the Helicobacter pylori mouse vaccination model

1 reference

12 December 2020

Helicobacter pylori utilises urea for amino acid synthesis.

1 reference

12 December 2020

Lactic acid bacteria as live vaccines.

1 reference

12 December 2020

Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice

1 reference

12 December 2020

Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses

1 reference

12 December 2020

Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis

1 reference

12 December 2020

Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge

1 reference

12 December 2020

Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production

1 reference

12 December 2020

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

1 reference

12 December 2020

High-Frequency Transformation, by Electroporation, of Lactococcus lactis subsp. cremoris Grown with Glycine in Osmotically Stabilized Media

1 reference

12 December 2020

Live bacterial delivery systems for development of mucosal vaccines

1 reference

12 December 2020

Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection

1 reference

12 December 2020

Heterologous protein production and delivery systems for Lactococcus lactis.

1 reference

12 December 2020

On the safety of lactic acid bacteria from food

1 reference

12 December 2020

10.1111/J.1574-695X.2009.00566.X

Identifiers

DOI

1 reference

5 February 2018

PMC publication ID

7110364

0 references

1 reference

5 February 2018